|
|
|
Human colorectal cancer HCT116 cells |
Overexpression of TRPV1 suppressed EGFR phosphorylation at Y1068 |
Proliferation ↓ |
70 |
|
|
|
Trpv1 knockout mice |
TRPV1 knockout increased constitutive EGFR Y1068 phosphorylation and PCNA, c-Fos and c-Myc expression levels |
Proliferation ↑ |
70 |
|
|
|
Human colorectal cancer HCT116 cells |
TRPV1 activation activates calpain and PTP1B, which dephosphorylates EGFR |
Proliferation ↓ |
70 |
|
|
|
Human melanoma A2058 and A375 cells |
Overexpression of TRPV1 activated p53 and, subsequently, upregulated its downstream target genes p21, PUMA, and mdm2 to induce apoptosis |
Proliferation ↓ |
71 |
|
|
|
Human pancreatic cancer cell line, PANC-1 |
Overexpression of TRPV1 downregulates EGFR levels by inducing EGFR ubiquitination and degradation |
Proliferation ↓ |
72 |
|
|
|
Human skin A431 cells |
Overexpression of TRPV1 promotes EGFR ubiquitylation and lysosomal degradation |
Proliferation ↓ |
73 |
Capsaicin |
100 |
24 |
Human urothelial cancer RT4 cells |
Induced cell cycle arrest in G0/G1 phase and apoptosis by activating p53 to upregulate Fas/CD95 in TRPV1-overexpressing cells |
Proliferation ↓ |
74 |
Capsaicin |
50-400 |
24-48 |
Human renal carcinoma 786-O cells |
Activated p38 and JNK MAPK pathways to induce apoptosis |
Proliferation ↓ |
75 |
Capsaicin |
0.1-20 |
48 |
Human prostate tumor androgen-responsive LNCaP cells |
Activated PI3K and p44/42 MAPK pathways to suppress ceramide production and increased androgen receptor expression |
Proliferation ↑ |
76 |
Capsaicin |
15 |
96-120 |
Human ESCC cell lines Eca109 |
|
Proliferation ↑ |
77 |
Capsaicin |
100 |
24 |
Human hepatocellular carcinoma PLC/PRF/5 cells |
Induced apoptosis by increasing the phosphorylation level of ERK and attenuating STAT3 phosphorylation |
Proliferation ↓ |
81 |
Capsaicin |
20 |
36 |
Human prostate tumor androgen-resistant PC-3 cells |
Induced apoptosis by producing ROS originating from the mitochondria and decreasing perturbations in the inner transmembrane potential (△Ψm) independently of TRPV1 |
Proliferation ↓ |
82 |
Capsaicin |
100 |
24-72 |
Human pancreatic neuroendocrine tumor BON and QGP-1 cells |
Disrupted mitochondrial membrane potential and suppressed ATP synthesis to induce apoptosis |
Proliferation ↓ |
83 |
Capsaicin |
75 |
24/48 |
Human nasopharyngeal carcinoma CNE2 and SUNE1 cells |
Inhibited MKK3-induced p38 activation |
Proliferation ↓ |
84 |
Capsaicin |
3 |
48/96 |
Human breast carcinoma cell line MCF-7 cells |
|
Proliferation ↑ |
90 |
Cannabidiol |
10 |
48 |
Human breast carcinoma cell line MBA-MD-231 cells |
Induced apoptosis via activation of CB2 and TRPV1 to elevate reactive oxygen species |
Proliferation ↓ |
78 |
Cannabidiol |
10 |
24 |
Human colon adenocarcinoma cell line Caco-2 cells |
Reduced the phosphorylation level of Akt, which was dependent on TRPV1 and CB1 |
Proliferation ↓ |
79 |
Noradrenaline |
100 |
24 |
Human prostate tumor androgen-resistant PC-3 cells |
Activated both alpha 1D-AR and TRPV1 and, subsequently, elicited the PLC/PKC/ERK pathways |
Proliferation ↑ |
80 |
Cannabigerol |
10 |
24 |
Human colon adenocarcinoma cell line Caco-2 cells |
Stimulated ROS generation, increased CHOP expression level, and promoted apoptosis |
Proliferation ↓ |
85 |
AEA |
10 |
24-72 |
The murine neuroblastoma cell line N1E-115 |
Seemed to occur via a lipid raft-dependent mechanism |
Proliferation ↓ |
86 |